Dow Jones

38,819.77

-0.17%

Regístrate para obtener gráficos en tiempo real, herramientas de análisis y precios.

Regístrate

Inicio
Invertir
Acciones
Estados Unidos
NASDAQ
Albany Molecular Research, Inc. (AMRI)
Albany Molecular Research, Inc. (AMRI) Noticias

AMRI

Albany Molecular Research, Inc. (AMRI)

Albany Molecular Research, Inc.

Fecha:

Regulatory News

Text Search:

Ordernar por:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:AMRI

1 2 3 4 5 6 Próxima >

Fecha	Hora	Fuente	Título	Símbolo	Compañía
14/02/2018	14:43	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	NASDAQ:AMRI	Albany Molecular Research, Inc.
25/09/2017	05:01	Edgar (US Regulatory)	Notice of Effectiveness (effect)	NASDAQ:AMRI	Albany Molecular Research, Inc.
12/09/2017	06:32	PR Newswire (US)	3ST Research Files Litigation Alleging Fraud and Conversion of Inventor's Intellectual Property Rights by Albany Molecular Re...	NASDAQ:AMRI	Albany Molecular Research, Inc.
05/09/2017	16:12	Edgar (US Regulatory)	Amended Statement of Beneficial Ownership (sc 13d/a)	NASDAQ:AMRI	Albany Molecular Research, Inc.
05/09/2017	15:52	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:AMRI	Albany Molecular Research, Inc.
31/08/2017	15:01	Edgar (US Regulatory)	(25-NSE)	NASDAQ:AMRI	Albany Molecular Research, Inc.
31/08/2017	12:38	Edgar (US Regulatory)	Termination of Registration of a Class of Security Under Section 12(b) (15-12b)	NASDAQ:AMRI	Albany Molecular Research, Inc.
31/08/2017	12:38	Edgar (US Regulatory)	Post-effective Amendment to Registration Statement (pos Am)	NASDAQ:AMRI	Albany Molecular Research, Inc.
31/08/2017	12:29	Edgar (US Regulatory)	Post-effective Amendment to an S-8 Filing (s-8 Pos)	NASDAQ:AMRI	Albany Molecular Research, Inc.
31/08/2017	12:18	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:AMRI	Albany Molecular Research, Inc.
31/08/2017	11:30	PR Newswire (US)	AMRI Announces Completion of Acquisition by The Carlyle Group and GTCR	NASDAQ:AMRI	Albany Molecular Research, Inc.
17/08/2017	16:47	PR Newswire (US)	Control4 Set to Join S&P SmallCap 600	NASDAQ:AMRI	Albany Molecular Research, Inc.
09/08/2017	13:36	Edgar (US Regulatory)	Quarterly Report (10-q)	NASDAQ:AMRI	Albany Molecular Research, Inc.
04/08/2017	15:30	Edgar (US Regulatory)	Additional Proxy Soliciting Materials (definitive) (defa14a)	NASDAQ:AMRI	Albany Molecular Research, Inc.
14/07/2017	16:26	Edgar (US Regulatory)	Proxy Statement - Merger or Acquistion (definitive) (defm14a)	NASDAQ:AMRI	Albany Molecular Research, Inc.
05/07/2017	15:51	PR Newswire (US)	SHAREHOLDER ALERT: Monteverde & Associates PC Announces An Investigation Of Albany Molecular Research, Inc. - AMRI	NASDAQ:AMRI	Albany Molecular Research, Inc.
03/07/2017	16:32	Edgar (US Regulatory)	Proxy Statement - Merger or Acquistion (preliminary) (prem14a)	NASDAQ:AMRI	Albany Molecular Research, Inc.
29/06/2017	07:00	PR Newswire (US)	AMRI Announces Early Termination of HSR Waiting Period for The Carlyle Group and GTCR's Proposed Acquisition of AMRI	NASDAQ:AMRI	Albany Molecular Research, Inc.
09/06/2017	12:42	PR Newswire (US)	WeissLaw LLP: The Proposed Acquisition of Albany Molecular Research Inc. May Not Be In the Best Interest of AMRI Shareholders	NASDAQ:AMRI	Albany Molecular Research, Inc.
07/06/2017	05:50	PR Newswire (US)	Stocks Under Scanner in the Biotech Space -- Paratek Pharma, Verastem, Alnylam Pharma, and Albany Molecular Research	NASDAQ:AMRI	Albany Molecular Research, Inc.
06/06/2017	06:30	PR Newswire (US)	AMRI Signs Definitive Agreement To Be Acquired By The Carlyle Group and GTCR for $21.75 per share in cash	NASDAQ:AMRI	Albany Molecular Research, Inc.
02/06/2017	08:15	PR Newswire (US)	AMRI to Present at Jefferies Healthcare Conference	NASDAQ:AMRI	Albany Molecular Research, Inc.
10/05/2017	05:05	Edgar (US Regulatory)	Amended Annual Report (10-k/a)	NASDAQ:AMRI	Albany Molecular Research, Inc.
09/05/2017	06:30	PR Newswire (US)	AMRI Announces First Quarter 2017 Results	NASDAQ:AMRI	Albany Molecular Research, Inc.
02/05/2017	07:00	PR Newswire (US)	AMRI Receives NIH Contract Award for Drug Substance Development and Manufacturing Services	NASDAQ:AMRI	Albany Molecular Research, Inc.
26/04/2017	07:00	PR Newswire (US)	SSCI Receives a 2017 Biotechnology Award for Global Research and Manufacturing	NASDAQ:AMRI	Albany Molecular Research, Inc.
25/04/2017	07:00	PR Newswire (US)	AMRI Schedules First Quarter 2017 Earnings Release and Conference Call	NASDAQ:AMRI	Albany Molecular Research, Inc.
24/04/2017	06:00	PR Newswire (US)	Denovo Biopharma Obtains Exclusive License To Liafensine From AMRI	NASDAQ:AMRI	Albany Molecular Research, Inc.
19/04/2017	15:41	Edgar (US Regulatory)	Proxy Statement (definitive) (def 14a)	NASDAQ:AMRI	Albany Molecular Research, Inc.
22/03/2017	13:38	PR Newswire (US)	AMRI Receives CMO Leadership Awards for Excellence	NASDAQ:AMRI	Albany Molecular Research, Inc.